hormone therapy – Medxy AI

Questioning Routine Hormone Therapy: No Survival Benefit for Low-PSA Recurrent Prostate Cancer Undergoing Postoperative Radiotherapy

By MedXY 03/06/2026

A large-scale individual patient data meta-analysis suggests that adding hormone therapy to postoperative radiotherapy does not improve overall survival for patients with low PSA levels, prompting a re-evaluation of current treatment standards for recurrent prostate cancer.

news Oncology

Postmenopausal Hormone Therapy: Balancing Endometrial Protection and Cancer Risk

By MedXY 12/16/2025

Updated evidence shows unopposed estrogen increases endometrial hyperplasia risk, while combined regimens offer better protection.

Cardiology news

Long-Term Hormone Therapy in Menopausal Women: Balancing Benefits and Risks

By MedXY 12/16/2025

Updated Cochrane review shows mixed outcomes for long-term hormone therapy in peri- and postmenopausal women.

Clinical Updates news OB/GYN & Women's Health Specialties

Top Ten Research Priorities in Menopause: A Comprehensive Evidence-Based Review

By MedXY 09/07/2025

This review synthesizes the Menopause Priority Setting Partnership findings, highlighting the top ten evidence-based research priorities addressing non-hormonal treatments, lifestyle interventions, cognitive and sleep changes, hormone therapy duration, global experiences, breast cancer management, dementia risk, and personalized hormone therapy safety.

Clinical Updates news OB/GYN & Women's Health Specialties

Estradiol Hormone Therapy Route Influences Memory Types in Postmenopausal Women

By MedXY 09/03/2025

Estradiol-based hormone therapy's impact on memory varies by administration route—with transdermal delivery linked to better episodic memory and oral delivery to improved prospective memory. Earlier menopause onset correlates with poorer cognitive performance.

news OB/GYN & Women's Health Oncology Specialties

Understanding Hormone Therapy and Breast Cancer Risk in Younger Women

By MedXY 07/29/2025

Recent research highlights that estrogen-only hormone therapy may reduce breast cancer risk in women under 55, while combined estrogen-progestin therapy could increase risk.

news OB/GYN & Women's Health Specialties

Rethinking Menopausal Hormone Therapy: Experts Urge FDA to Revise Outdated Warnings

By MedXY 07/29/2025

Leading experts call on the FDA to update boxed warnings on menopausal hormone therapies, arguing current labels are outdated and deter women from effective, safe treatments.

Diabetes & Endocrinology news OB/GYN & Women's Health Specialties

Enhanced Weight Loss for Menopausal Women: The Role of Tirzepatide and Hormone Therapy

By MedXY 07/29/2025

A new study reveals combining tirzepatide and hormone therapy significantly boosts weight loss in postmenopausal women, offering a promising approach to managing obesity-related health risks.